Elon Musk’s Neuralink says 21 people are now in its brain-chip trials — up from 12
Neuralink, Elon Musk’s brain implant company, announced Wednesday that it now has 21 participants enrolled in its trials worldwide, two years after starting human testing. This is an increase from the 12 users reported last September, who were already controlling digital and physical devices with their thoughts. The company targets people with conditions like spinal cord injuries and says it hasn’t recorded any serious device-related adverse events. Neuralink added that expanding the trials will help it “better understand these variations” and refine both its hardware and implantation procedures. This new number is significant since Neuralink has shared very few concrete stats while pushing to expand its tightly scrutinized experiment into a wider clinical trial. Having more participants allows companies to